Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

MicroRNAs as an emerging target for melanoma therapy.

Ryu B, Hwang S, Alani RM.

J Invest Dermatol. 2013 May;133(5):1137-9. doi: 10.1038/jid.2012.505.

2.

miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Bennett PE, Bemis L, Norris DA, Shellman YG.

Physiol Genomics. 2013 Nov 15;45(22):1049-59. doi: 10.1152/physiolgenomics.00116.2013. Review.

3.

The role of microRNAs in melanoma.

Luo C, Weber CE, Osen W, Bosserhoff AK, Eichmüller SB.

Eur J Cell Biol. 2014 Jan-Feb;93(1-2):11-22. doi: 10.1016/j.ejcb.2014.02.001. Review.

PMID:
24602414
4.

MicroRNA regulation of melanoma progression.

Bonazzi VF, Stark MS, Hayward NK.

Melanoma Res. 2012 Apr;22(2):101-13. doi: 10.1097/CMR.0b013e32834f6fbb. Review.

PMID:
22209751
5.

MicroRNA-221 and -222 pathway controls melanoma progression.

Felicetti F, Errico MC, Segnalini P, Mattia G, Carè A.

Expert Rev Anticancer Ther. 2008 Nov;8(11):1759-65. doi: 10.1586/14737140.8.11.1759. Review.

PMID:
18983236
6.

MicroRNAs in malignant melanoma.

Völler D, Ott C, Bosserhoff A.

Clin Biochem. 2013 Jul;46(10-11):909-17. doi: 10.1016/j.clinbiochem.2013.01.008. Review.

PMID:
23360785
7.

MicroRNAs in cancer: lessons from melanoma.

Greenberg E, Nemlich Y, Markel G.

Curr Pharm Des. 2014;20(33):5246-59. Review.

PMID:
24479804
8.

MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.

Greene CM, Varley RB, Lawless MW.

World J Gastroenterol. 2013 Aug 28;19(32):5212-26. doi: 10.3748/wjg.v19.i32.5212. Review.

Items per page

Supplemental Content

Support Center